NAKAKOSHI MASAMICHI
No ORCID on file
· 33 papers in corpus
· active 1999-2002
Frequent coauthors
- YOSHIHAMA MAKOTO 33
- IKEDA YOSHIKAZU 22
- NOMOTO SHIN 22
- HARTMANN ROLF WOLFGANG 22
- WACHALL BERTIL 22
- TAKAHASHI KOUSAKU 11
- NAKAMURA JUNJI 11
- NAKAYAMA SHOUJI 11
2002
Dihydronaphthalene compounds have excellent 17alpha-hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic …
2002
Dihydronaphthalene compounds have excellent 17alpha-hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic …
2002
Dihydronaphthalene compounds have excellent 17alpha-hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic …
2002
Dihydronaphthalene compounds have excellent 17alpha-hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic …
2002
Dihydronaphthalene compounds have excellent 17alpha-hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic …
2002
Dihydronaphthalene compounds have excellent 17alpha-hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic …
2002
Dihydronaphthalene compounds have excellent 17alpha-hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic …
2002
Dihydronaphthalene compounds have excellent 17alpha-hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic …
2002
Dihydronaphthalene compounds have excellent 17alpha-hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic …
2002
Dihydronaphthalene compounds have excellent 17alpha-hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic …
2002
Dihydronaphthalene compounds have excellent 17alpha-hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic …
2000
Dihydronaphthalene compounds have excellent 17 alpha -hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic a…
2000
Dihydronaphthalene compounds have excellent 17 alpha -hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic a…
2000
Dihydronaphthalene compounds have excellent 17 alpha -hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic a…
2000
Dihydronaphthalene compounds have excellent 17 alpha -hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic a…
2000
Dihydronaphthalene compounds have excellent 17 alpha -hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic a…
2000
Dihydronaphthalene compounds have excellent 17 alpha -hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic a…
2000
Dihydronaphthalene compounds have excellent 17 alpha -hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic a…
2000
Dihydronaphthalene compounds have excellent 17 alpha -hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic a…
2000
Dihydronaphthalene compounds have excellent 17 alpha -hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic a…
2000
Dihydronaphthalene compounds have excellent 17 alpha -hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic a…
2000
Dihydronaphthalene compounds have excellent 17 alpha -hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic a…
1999
Remedies for hormone-dependent disease which have a 17 beta -HSD inhibitory activity and are useful, owing to this activity, in preventing and/or treating male and female hormone-dependent diseases, more particularly prostatic cancer, prost…
1999
Remedies for hormone-dependent disease which have a 17 beta -HSD inhibitory activity and are useful, owing to this activity, in preventing and/or treating male and female hormone-dependent diseases, more particularly prostatic cancer, prost…
1999
Remedies for hormone-dependent disease which have a 17 beta -HSD inhibitory activity and are useful, owing to this activity, in preventing and/or treating male and female hormone-dependent diseases, more particularly prostatic cancer, prost…